Sadayoshi Ito Selected Research

1- (5- hydroxy- 3- methyl- 1- phenyl- 1H- pyrazol- 4- yl)- 6- methyl- 1,3- dihydrofuro(3,4- c)pyridine- 7- ol

8/2009

Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sadayoshi Ito Research Topics

Disease

55	Hypertension (High Blood Pressure) 01/2022 - 09/2003
32	Diabetic Nephropathies (Diabetic Nephropathy) 07/2022 - 09/2003
32	Chronic Renal Insufficiency 01/2022 - 12/2007
21	Albuminuria 07/2022 - 01/2005
19	Inflammation (Inflammations) 11/2021 - 12/2002
19	Hyperaldosteronism (Conn Syndrome) 01/2021 - 08/2006
19	Adenoma (Adenomas) 01/2019 - 07/2006
18	Proteinuria 01/2021 - 12/2002
18	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2003
18	Neoplasms (Cancer) 01/2020 - 08/2003
17	Type 2 Diabetes Mellitus (MODY) 10/2021 - 08/2003
16	Renal Insufficiency (Renal Failure) 11/2021 - 09/2004
14	Fibrosis (Cirrhosis) 02/2021 - 08/2005
12	Stroke (Strokes) 11/2018 - 03/2008
10	Insulin Resistance 01/2022 - 02/2002
10	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 01/2003
10	Thyroiditis 01/2013 - 12/2002
9	Essential Hypertension 01/2022 - 04/2003
9	Atherosclerosis 12/2013 - 03/2002
9	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2013 - 12/2002
8	Pre-Eclampsia (Preeclampsia) 06/2020 - 11/2016
8	Heart Failure 01/2017 - 08/2003
7	Diabetes Mellitus 01/2018 - 01/2003
6	Ischemia 05/2019 - 07/2011
6	Hyperplasia 10/2018 - 02/2014
6	Renal Artery Obstruction (Renal Artery Stenosis) 11/2010 - 03/2005
5	Kidney Diseases (Kidney Disease) 11/2021 - 10/2008
5	Body Weight (Weight, Body) 10/2020 - 01/2010
5	Obesity 10/2020 - 12/2003
5	Adrenocortical Adenoma (Disease, Conn's) 01/2020 - 08/2003
5	Wounds and Injuries (Trauma) 10/2019 - 02/2009
4	Acute Kidney Injury (Acute Renal Failure) 05/2019 - 01/2003
4	Mitochondrial Diseases (Mitochondrial Disease) 06/2017 - 01/2015
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021 - 12/2003
3	Atrophy 01/2021 - 08/2003
3	Hyperuricemia 01/2021 - 12/2018
3	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2020 - 11/2016
3	Hypoxia (Hypoxemia) 01/2020 - 02/2016
3	Hyperkalemia 12/2019 - 01/2019
3	Hypotension (Low Blood Pressure) 10/2019 - 01/2014
3	Infections 11/2018 - 04/2000

Drug/Important Bio-Agent (IBA)

31	AldosteroneIBA 10/2020 - 08/2003
23	CreatinineIBA 07/2022 - 10/2003
21	Antihypertensive Agents (Antihypertensives)IBA 07/2022 - 06/2003
17	AlbuminsIBA 07/2022 - 02/2004
15	Angiotensin Receptor AntagonistsIBA 11/2015 - 10/2003
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2000
13	Angiotensin IIIBA 08/2012 - 08/2005
12	esaxerenoneIBA 07/2022 - 01/2019
11	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 12/2003
11	ReninIBA 02/2021 - 10/2003
10	Uremic ToxinsIBA 11/2021 - 12/2009
10	Pharmaceutical PreparationsIBA 01/2021 - 08/2005
10	olmesartanIBA 03/2016 - 09/2006
10	Losartan (Cozaar)FDA LinkGeneric 08/2012 - 06/2003
9	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022 - 01/2019
9	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2020 - 02/2011
9	Messenger RNA (mRNA)IBA 04/2019 - 12/2002
8	Adenine FDA LinkGeneric 11/2021 - 08/2015
8	SaltsIBA 01/2020 - 02/2009
8	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2019 - 04/2003
7	Uric Acid (Urate)IBA 01/2021 - 06/2010
6	Niacinamide (Nicotinamide)FDA LinkGeneric 11/2021 - 11/2016
6	SteroidsIBA 06/2019 - 03/2002
6	EnzymesIBA 01/2019 - 02/2004
6	IodidesIBA 01/2013 - 12/2002
5	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2010
5	Biological ProductsIBA 01/2019 - 10/2005
5	Pyruvaldehyde (Methylglyoxal)IBA 01/2018 - 10/2008
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2013 - 04/2003
5	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 12/2013 - 08/2011
4	Blood Glucose (Blood Sugar)IBA 12/2021 - 09/2008
4	Tolvaptan FDA Link 04/2019 - 01/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2017 - 06/2009
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 11/2004
4	DiureticsIBA 01/2017 - 10/2014
4	benidipineIBA 12/2013 - 08/2011
3	PotassiumIBA 07/2022 - 01/2008
3	SodiumIBA 07/2022 - 01/2003
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 05/2006
3	HydrogenIBA 01/2022 - 09/2010
3	AST 120IBA 01/2020 - 11/2012
3	Insulin (Novolin)FDA Link 11/2019 - 12/2003
3	CytokinesIBA 10/2019 - 01/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2019 - 01/2018
3	Erythropoietin FDA Link 01/2019 - 10/2013
3	PAR-2 ReceptorIBA 01/2019 - 01/2016
3	Factor Xa (Coagulation Factor Xa)IBA 01/2019 - 01/2016
3	18-oxocortisolIBA 01/2019 - 08/2011
3	Renin InhibitorsIBA 01/2019 - 11/2011
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 09/2011
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 01/2006
3	Mitochondrial DNA (mtDNA)IBA 01/2018 - 01/2015

Therapy/Procedure

46	Therapeutics 07/2022 - 03/2002
6	Renal Dialysis (Hemodialysis) 09/2020 - 09/2004
6	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2020 - 10/2015
5	Peritoneal Dialysis 11/2018 - 01/2016
4	Adrenalectomy 03/2016 - 07/2011
4	Glycemic Control 01/2013 - 01/2010